C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: a nationwide prospective cohort study
Authors:
- Huiwen OuHOHuiwen Ou
- Xiaoshuang XiaXXXiaoshuang Xia
- Xin LiXLXin Li
Preprint
- 29 May 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Objective The American Heart Association (AHA) developed the notion of cardiovascular-kidney-metabolic (CKM) syndrome, which emphasizes the interconnection of heart, kidney, and metabolic illnesses. The C-reactive protein-triglyceride-glucose (CTI) represents a potential indicator to assess the resistance to insulin and an inflammatory response. However, the connection among CTI, cardiovascular disease (CVD) incidence, and overall mortality rates remains uncertain, particularly among individuals at CKM stages 0-3. Methods The China Health and Retirement Longitudinal Study (CHARLS) enrolled 17,705 middle-aged and elderly people. The primary outcome was the occurrence of CVD and overall mortality rates. The CTI was obtained by 0.412* Ln (CRP [mg/L]) + Ln (TG [mg/dl] × FPG [mg/dl])/2. The correlation among CTI and CVD incidence and overall mortality was assessed via Cox proportional hazard models, Kaplan-Meier curves and restricted cubic spline (RCS) analysis. To improve the study results, a stratified analysis evaluated the influence of varying socio-demographic characteristics. Results During a 9-years following-up, 5534 participants (9.2%) experienced a CVD event, while 121 participants (2.1%) experienced all-cause mortality. RCS analysis revealed a notable non-linear association between CTI and CVD occurrence, as well as a linear association between CTI and all-cause death. After comprehensive multivariate adjustment, the data showed a striking 97% increase in overall mortality risk for every 1-unit rise in continuous CTI measurements. Conclusions Findings show that higher CTI levels independently forecast CVD and death, highlighting its potential as a biomarker for individuals with CKM stages 0-3.Keywords
All Related Versions
This publication has 26 references indexed in Scilit:
- Association Between Triglyceride–Glucose Index and Carotid Plaque Stability in Different Glycemic Status: A Single‐Center Retrospective StudyJournal of the American Heart Association, 2025
- Association between C-reactive protein-triglyceride glucose index and depressive symptoms in American adults: results from the NHANES 2005 to 2010BMC Psychiatry, 2024
- A linear positive association between high-sensitivity C-reactive protein and the prevalence of cardiovascular disease among individuals with diabetesBMC Cardiovascular Disorders, 2024
- Associations between insulin resistance indices and subclinical atherosclerosis: A contemporary reviewAmerican Journal of Preventive Cardiology, 2024
- Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart AssociationCirculation, 2023
- Effect of dual residual risk of cholesterol and inflammation on all-cause mortality in patients with cardiovascular diseaseCardiovascular Diabetology, 2023
- Association of Depressive Symptoms With Incident Cardiovascular Diseases in Middle-Aged and Older Chinese AdultsJAMA Network Open, 2019
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJournal of Clinical Investigation, 2006
- Adhesion molecules and atherogenesisActa Physiologica Scandinavica, 2001